And yet the head of a federal panel that will be issuing health guidelines for the rest of us has been unable to resist drug company money. She
has been a member of speaker bureaus for two drug companies, Daiichi Sankyo and Novartis. Some universities prohibit faculty involvement with speaker bureaus to avoid claims of marketing.
“The fact is you get pursued by the companies,” Dr. Oparil said. “On some occasions, I’ve said yes to them.”
The girl can’t help it.